TENAX THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tenax Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2011 to Q2 2024.
  • Tenax Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.96M shares, a 91.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.96M -21.9M -91.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.96M -19.8M -91% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 298K +270K Dec 31, 2023 10-Q 2024-08-13
Q3 2023 23.9M -6.12M -20.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 23.9M -1.34M -5.33% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 21.8M -3.43M -13.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 28.6K* -1.23M Dec 31, 2022 10-K 2024-03-28
Q3 2022 30M +4.78M +19% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 25.2M -3.4K -0.01% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 25.2M +10.2M +68.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 1.26M -11.4M -90% Dec 31, 2021 10-K 2023-03-31
Q3 2021 25.2M +12.6M +99.7% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 25.2M +15.1M +150% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 15M +6.96M +86.9% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 12.6M +5.88M +87.2% Dec 31, 2020 10-K 2022-03-29
Q3 2020 12.6M +5.88M +87.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 10.1M +3.43M +51.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 8.01M +1.85M +30.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 6.74M +2.95M +77.8% Dec 31, 2019 10-K/A 2021-04-16
Q3 2019 6.74M +5.28M +360% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 6.67M +5.22M +359% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 6.15M +4.7M +323% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 3.79M +2.38M +169% Dec 31, 2018 10-K 2020-03-30
Q3 2018 1.47M -26.8M -94.8% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 1.45M -26.8M -94.9% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 1.45M -26.8M -94.9% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 1.41M +5.84K +0.42% Dec 31, 2017 10-K 2019-04-01
Q3 2017 28.2M +117K +0.42% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 28.2M +117K +0.42% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 28.2M +117K +0.42% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 1.41M -26.7M -95% Dec 31, 2016 10-K 2018-04-02
Q3 2016 28.1M +240 +0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 28.1M +240 +0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 28.1M +251 +0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.1M +258 +0% Dec 31, 2015 10-K 2017-03-16
Q3 2015 28.1M +335 +0% Oct 31, 2015 10-Q 2015-12-10
Q2 2015 28.1M +12.3K +0.04% Jul 31, 2015 10-Q 2015-09-09
Q1 2015 28.1M +262K +0.94% Apr 30, 2015 10-KT 2016-03-14
Q4 2014 28.1M +21.3M +313% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 28.1M +21.3M +313% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 28.1M +25M +818% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 27.9M +25.9M +1343% Apr 30, 2014 10-KT 2016-03-14
Q4 2013 6.81M -26.8M -79.8% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 6.81M -26.1M -79.3% Oct 31, 2013 10-Q 2013-12-17
Q2 2013 3.06M -28M -90.1% Jul 31, 2013 10-Q 2013-09-17
Q1 2013 1.93M +459K +31.2% Apr 30, 2013 10-K 2014-07-29
Q4 2012 33.7M +5.42M +19.2% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 32.9M +9.04M +37.9% Oct 31, 2012 10-Q 2012-12-14
Q2 2012 31.1M +7.67M +32.8% Jul 31, 2012 10-Q 2012-09-19
Q1 2012 1.47M -21.9M -93.7% Apr 30, 2012 10-K 2013-06-26
Q4 2011 28.2M Jan 31, 2012 10-Q 2012-03-15
Q3 2011 23.9M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 23.4M Jul 31, 2011 10-Q 2011-09-19
Q1 2011 23.4M Apr 30, 2011 10-K 2012-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.